11.1 Information on toxicological effects
Acute toxicity
Oral: No data available
Inhalation: No data available
Dermal: No data available
Skin corrosion/irritation
Skin - In vitro study
Result: Corrosive after 1 to 4 hours of exposure (OECD Test Guideline 431)
Remarks: (Regulation (EC) No 1272/2008, Annex VI)
Serious eye damage/eye irritation
Classified based on available data. For more details, see section 2
Respiratory or skin sensitization
Classified based on available data. For more details, see section 2
Germ cell mutagenicity
Classified based on available data. For more details, see section 2
Test Type: Ames test
Test system: S. typhimurium
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 471
Result: Positive results were obtained in some in vitro tests.
Carcinogenicity
May cause cancer by inhalation.
Reproductive toxicity
Classified based on available data. For more details, see section 2
Classified based on available data. For more details, see section 2
Specific target organ toxicity - single exposure
Classified based on available data. For more details, see section 2
Specific target organ toxicity - repeated exposure
Classified based on available data. For more details, see section 2
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.
Chromium(VI) is highly toxic. It is absorbed via both the lungs and the gastrointestinal tract. Being strong oxidisers, chromates/ bichromates can cause burns and ulcerations on the skin and mucous membranes and also irritations in the upper respiratory tract. Poorly healing ulcers occur after wound contact. In predisposed persons the substance rapidly leads to sensitisation and allergic reactions of the respiratory tract (risk of pneumonia!) and damage to nasal mucous membranes (under given circumstances perforation of the septum). After swallowing severe symptoms in the gastrointestinal tract such as bloody diarrhoea, vomiting (aspiration pneumonia!), spasms, circulatory collapse, unconsciousness, formation of methaemoglobin. Absorption may result in hepatic and renal damage. Inhalable chromium(VI) compounds gave clear evidence to be carcinogenic in animal experiments. Lethal dose (man): 0.5g. Antidotes: chelating agents such as EDTA,
DMPS (Demaval®)
This substance should be handled with particular care.